Diabetes technology

Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes

Diabetes Technol TherPublished Multicentre observational study

Authors' conclusion

In older adults with T1D, real-world aHCL initiation was associated with improved glycemic outcomes and better glycemic outcomes than in matched MDI users in a cohort with substantial cognitive vulnerability.

Study context

Population
Older adults with T1D who initiated advanced hybrid closed-loop (aHCL) at ≥65 years, 19 Spanish hospitals; mean age 71.2 ± 4.4 yearsmatched
Participants
100 vs 100
Exposure
aHCL vs matched MDI; and before vs after aHCL initiation
  • aHCLn = 100
  • MDIn = 100reference
Outcome
TIR 70-180 mg/dL, aHCL users before initiation vs final follow-up
Follow-up
Final
Methodological detailsreal-world, age- and sex-matched MDI comparison group
  • Real-world
  • Age- and sex-matched MDI comparison group

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

TIR, aHCL vs matched MDI · final follow-up

P < 0.001

HbA1c, aHCL vs matched MDI · final follow-up

P < 0.001

OutcomeP value
HbA1c, aHCL users before initiation vs final follow-upP < 0.001
  • HbA1c, aHCL users before initiation vs final follow-up: aHCL (before initiation) mean 7.56% (SD 0.97%)
  • HbA1c, aHCL users before initiation vs final follow-up: aHCL (final follow-up) mean 7.01% (SD 0.59%)
  • HbA1c, aHCL users before initiation vs final follow-up: 59.1 ± 10.6 mmol/mol to 53.1 ± 6.4 mmol/mol
  • HbA1c, aHCL vs matched MDI: 53.1 ± 6.4 mmol/mol to 59.9 ± 10.7 mmol/mol

Cognition in aHCL users

aHCL users with mild-to-moderate cognitive impairment
60%
Final TIR similar across cognitive strata within aHCL

Safety

Events per 100 patient-years

OutcomeaHCL (before initiation)aHCL (after initiation)
Severe hypoglycaemia, aHCL users28.01.6

Original publication

Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes. Diabetes Technol Ther. Published 3 August 2026. doi:10.1177/15209156261474587

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.